Your browser doesn't support javascript.
loading
Shwachman-Bodian-Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia.
Dun, Matthew D; Mannan, Abdul; Rigby, Callum J; Butler, Stephen; Toop, Hamish D; Beck, Dominik; Connerty, Patrick; Sillar, Jonathan; Kahl, Richard G S; Duchatel, Ryan J; Germon, Zacary; Faulkner, Sam; Chi, Mengna; Skerrett-Byrne, David; Murray, Heather C; Flanagan, Hayley; Almazi, Juhura G; Hondermarck, Hubert; Nixon, Brett; De Iuliis, Geoff; Chamberlain, Janis; Alvaro, Frank; de Bock, Charles E; Morris, Jonathan C; Enjeti, Anoop K; Verrills, Nicole M.
Afiliação
  • Dun MD; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia. matt.dun@newcastle.edu.au.
  • Mannan A; Hunter Medical Research Institute, Cancer Research Program, New Lambton Heights, NSW, Australia. matt.dun@newcastle.edu.au.
  • Rigby CJ; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
  • Butler S; Hunter Medical Research Institute, Cancer Research Program, New Lambton Heights, NSW, Australia.
  • Toop HD; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
  • Beck D; Hunter Medical Research Institute, Cancer Research Program, New Lambton Heights, NSW, Australia.
  • Connerty P; School of Chemistry, University of New South Wales, Sydney, NSW, Australia.
  • Sillar J; School of Chemistry, University of New South Wales, Sydney, NSW, Australia.
  • Kahl RGS; Centre for Health Technologies and the School of Biomedical Engineering, University of Technology Sydney, Sydney, Australia.
  • Duchatel RJ; Lowy Cancer Research Centre and the Prince of Wales Clinical School, University of New South Wales, Sydney, Australia.
  • Germon Z; Children's Cancer Institute Australia, University of New South Wales, Sydney, NSW, Australia.
  • Faulkner S; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
  • Chi M; Hunter Medical Research Institute, Cancer Research Program, New Lambton Heights, NSW, Australia.
  • Skerrett-Byrne D; Calvary Mater Hospital, Newcastle, NSW, Australia.
  • Murray HC; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
  • Flanagan H; Hunter Medical Research Institute, Cancer Research Program, New Lambton Heights, NSW, Australia.
  • Almazi JG; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
  • Hondermarck H; Hunter Medical Research Institute, Cancer Research Program, New Lambton Heights, NSW, Australia.
  • Nixon B; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
  • De Iuliis G; Hunter Medical Research Institute, Cancer Research Program, New Lambton Heights, NSW, Australia.
  • Chamberlain J; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
  • Alvaro F; Hunter Medical Research Institute, Cancer Research Program, New Lambton Heights, NSW, Australia.
  • de Bock CE; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
  • Morris JC; Hunter Medical Research Institute, Cancer Research Program, New Lambton Heights, NSW, Australia.
  • Enjeti AK; Reproductive Science Group, Faculty of Science, University of Newcastle, Callaghan, NSW, Australia.
  • Verrills NM; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
Leukemia ; 34(12): 3393-3397, 2020 12.
Article em En | MEDLINE | ID: mdl-32269318

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Proteína Fosfatase 2 / Síndrome de Shwachman-Diamond Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Proteína Fosfatase 2 / Síndrome de Shwachman-Diamond Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália